Enhance MD vs IVIM Health: Pricing, Protocols, Reviews
The Enhance MD vs IVIM Health comparison hinges on three clear differences: introductory pricing and flat-rate policy, program structure and published satisfaction, and compound options. Brief verdict: Enhance MD is the lower-cost entry with flat-rate pricing; IVIM Health emphasizes clinician-guided protocols and unusually strong third-party ratings.
Start Enhance MD: See $49 semaglutide first month
Key difference 1: Introductory price and ongoing pricing model
Enhance MD advertises semaglutide starting at $49 for the first month and tirzepatide from $99 for the first month, with flat-rate pricing that the provider says stays the same at every dose and no fee escalation during titration. IVIM Health lists semaglutide at $75 per month and offers a free month membership with code GIFT75; IVIM also lists a $99 first month in its FAQ and a $174/month ongoing rate in published materials. Both platforms use compounded medications; each note that compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality.
Key difference 2: Program structure and clinical protocol
Enhance MD positions itself as a multi-option GLP-1 platform that offers both semaglutide and tirzepatide on the same platform and flat-rate dosing to avoid dose-based price increases. IVIM Health offers a proprietary GLP-1 ID protocol described as a clinician-guided titration and optimization approach that the provider claims can accelerate weight loss outcomes by up to 40 percent compared to standard protocols; IVIM describes this as a proprietary protocol claim, not an independent randomized trial.
Direct comparison on program features
| Criteria | Enhance MD | IVIM Health |
|---|---|---|
| Starting price (semaglutide) | Starting at $49 first month | $75/mo; free month with code GIFT75 |
| Ongoing pricing model | Flat-rate pricing: same price at every dose, no escalation | Published $174/month ongoing; first month may be $99 per FAQ |
| Compound options | Compounded semaglutide and tirzepatide available | Compounded semaglutide and tirzepatide available |
| Program protocol | Clinician-directed compounds; standard telehealth model | Proprietary GLP-1 ID clinician-guided protocol claiming up to 40 percent faster outcomes |
| Third-party validation | 10,000+ patients treated cited | 4.9-star rating on Google and Trustpilot reported |
Explore IVIM Health: Free month code GIFT75
Key difference 3: Evidence, volume, and trust signals
Enhance MD highlights patient volume, noting more than 10,000 patients treated, which the provider uses to support real-world experience with compounded semaglutide and tirzepatide. IVIM Health emphasizes external satisfaction metrics, listing a 4.9-star rating on both Google and Trustpilot and referencing retrospective observational studies and internal data related to outcomes under its protocol. IVIM also offers a no-obligation free consultation described as a $75 value for new patients.
Safety, regulatory, and prescribing notes
Both providers state that their compounded medications are not FDA-approved and have not been reviewed by FDA for safety, effectiveness, or quality. Each requires a clinician review and prescription where medically appropriate; IVIM specifies that compounded medications are prepared by independent, licensed compounding pharmacies and may not be available in all states. Enhance MD notes treatment is available only when a licensed clinician determines it is medically appropriate. These statements preserve each provider’s published qualifications and limitations.
Compare Enhance MD pricing and flat-rate details
Which provider fits your priorities?
Use the primary keyword when weighing options: Enhance MD vs IVIM Health. Choose based on whether upfront cost, a structured protocol, or third-party ratings matter most to you. Enhance MD is positioned for people seeking the lowest first-month entry and flat-rate dose pricing across semaglutide and tirzepatide on one platform. IVIM Health is positioned for patients who prioritize clinician-guided optimization, external satisfaction scores, and a structured membership that can include a free month with code GIFT75 and a free consultation.
Get IVIM Health consult and membership info
Start with Enhance MD: Review clinician requirements
Choose one if…
- Choose Enhance MD if you want the lowest reported first-month pricing and flat-rate dosing across semaglutide and tirzepatide, and you value multi-compound access on one platform. Fees are described as first-month introductory rates and ongoing flat rates are higher; compounded medications are not FDA-approved.
- Choose IVIM Health if you value high third-party ratings, a proprietary clinician-guided GLP-1 ID protocol that IVIM says can accelerate outcomes, and offers like a free month with code GIFT75 plus a no-obligation free consultation. IVIM publishes ongoing pricing and notes that the protocol claim is proprietary and not a randomized head-to-head trial.
Comparing Enhance MD vs IVIM Health requires matching your budget tolerance, desire for a structured protocol, and response to external reviews. Both use compounded GLP-1 medications and require clinician review. If a gap in evidence exists for outcomes between these platforms, that is not supplied in the source materials and is not stated here.